![Wills Hughes-Wilson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Wills Hughes-Wilson
Corporate Officer/Principal en MEREO BIOPHARMA GROUP PLC .
Fortuna: 233 392 $ al 31/05/2024
Cargos activos de Wills Hughes-Wilson
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
MEREO BIOPHARMA GROUP PLC | Corporate Officer/Principal | 01/03/2018 | - |
Historial de carrera de Wills Hughes-Wilson
Antiguos cargos conocidos de Wills Hughes-Wilson.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SWEDISH ORPHAN BIOVITRUM AB | Public Communications Contact | 04/07/2012 | 01/01/2018 |
Consejero General | 01/02/2012 | 04/07/2012 | |
Corporate Officer/Principal | 01/02/2012 | 01/01/2018 | |
Genzyme Therapeutics Ltd.
![]() Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - | - |
European Biopharmaceutical Enterprises
![]() European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium. | Director/Miembro de la Junta | - | - |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Formación de Wills Hughes-Wilson.
University of Durham | Graduate Degree |
Estadísticas
Internacional
Reino Unido | 4 |
Suecia | 2 |
Estados Unidos | 2 |
Operativa
Corporate Officer/Principal | 4 |
Public Communications Contact | 1 |
General Counsel | 1 |
Sectorial
Health Technology | 6 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
MEREO BIOPHARMA GROUP PLC | Health Technology |
Empresas privadas | 3 |
---|---|
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
European Biopharmaceutical Enterprises
![]() European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium. | Health Technology |
Genzyme Therapeutics Ltd.
![]() Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Wills Hughes-Wilson
- Experiencia